Effectiveness of anlotinib in patients with small‐cell lung cancer and pleural effusion: Subgroup analysis from a randomized, multicenter, phase II study-Reference-Cited by-同舟云学术

Effectiveness of anlotinib in patients with small‐cell lung cancer and pleural effusion: Subgroup analysis from a randomized, multicenter, phase II study

Published:2021-10 Issue:22 Volume:12 Page:3039-3045
ISSN:1759-7706
Container-title:Thoracic Cancer
language:en
Short-container-title:Thorac Cancer

Author:

Liu Ying¹,Cheng Ying¹^ORCID,Wang Qiming²,Li Kai³,Shi Jianhua⁴,Wu Lin⁵,Han Baohui⁶,Chen Gongyan⁷,He Jianxing⁸,Wang Jie⁹^ORCID,Qin Haifeng¹⁰,Li Xiaoling¹¹

Affiliation:

1. Department of Thoracic Medical Oncology Jilin Cancer Hospital Changchun China

2. Department of Internal Medicine Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital Zhengzhou China

3. Department of Pulmonary Oncology Tianjin Medical University Cancer Institute and Hospital Tianjin China

4. Department of Medical Oncology Shandong Linyi Tumor Hospital Linyi China

5. Department of Thoracic Medical Oncology The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University (Hunan Cancer Hospital) Changsha China

6. Department of Respiratory Medicine Shanghai Chest Hospital, Shanghai Jiaotong University Shanghai China

7. Department of Respiratory Medicine Harbin Medical University Cancer Hospital Harbin China

8. Department of Thoracic Surgery The First Affiliated Hospital of Guangzhou Medical University Guangzhou China

9. Department of Thoracic Medical Oncology Cancer Hospital Chinese Academy of Medical Sciences Beijing China

10. Department of Pulmonary Oncology The Fifth Medical Centre of Chinese PLA General Hospital Beijing China

11. Department of Medical Oncology Liaoning Cancer Hospital Shenyang China

Funder

Jilin Provincial Health and Family Planning Commission

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1759-7714.14176

Reference27 articles.

1. International lung cancer trends by histologic type: Male:Female differences diminishing and adenocarcinoma rates rising

2. The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals Regarding the Clinical Staging of Small Cell Lung Cancer in the Forthcoming (Seventh) Edition of the Tumor, Node, Metastasis Classification for Lung Cancer

3. The IASLC Lung Cancer Staging Project: Proposals for Revision of the M Descriptors in the Forthcoming (Seventh) Edition of the TNM Classification of Lung Cancer

4. Malignant Pleural Effusion at Presentation in Patients with Small-Cell Lung Cancer

5. Minimal Pleural Effusion in Small Cell Lung Cancer: Proportion, Mechanisms, and Prognostic Effect

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison between different treatment regimens of vascular targeting drug to malignant pleural effusion in patients with lung cancer: A Bayesian network meta-analysis;Medicine;2023-07-21

2. A single-arm phase II clinical trial of anlotinib combined with chemotherapy for the treatment of metastatic triple-negative breast cancer;Frontiers in Oncology;2023-04-12

3. Anlotinib plus etoposide increases survival in patients with small-cell lung cancer after chemoradiotherapy;Journal of Radiation Research and Applied Sciences;2022-12